{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:46:28Z","timestamp":1785350788982,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215793\/Z\/19\/Z"],"award-info":[{"award-number":["215793\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["MR\/T003138\/1"],"award-info":[{"award-number":["MR\/T003138\/1"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.schres.2023.02.011","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T13:23:53Z","timestamp":1676467433000},"page":"54-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Characteristics and clinical correlates of risk symptoms in individuals at clinical high-risk for psychosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"254","author":[{"given":"Saskia M.","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fusar-Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Uhlhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2023.02.011_bb0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.schres.2007.10.001","article-title":"Social functioning in individuals at clinical high risk for psychosis","volume":"99","author":"Addington","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.02.011_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41537-020-00117-0","article-title":"Progression from being at-risk to psychosis: next steps","volume":"6","author":"Addington","year":"2020","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.schres.2023.02.011_bb0015","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1017\/S0033291717003002","article-title":"Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis","volume":"48","author":"Allott","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2023.02.011_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2012.08.017","article-title":"Duration of untreated psychosis and negative symptoms \u2013 a systematic review and meta-analysis of individual patient data","volume":"142","author":"Boonstra","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.02.011_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/acps.12261","article-title":"Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis","volume":"130","author":"Bora","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.02.011_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.schres.2017.06.021","article-title":"Duration of untreated psychosis and neurocognition in first-episode psychosis: a meta-analysis","volume":"193","author":"Bora","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.02.011_bb0035","series-title":"Introduction to Meta-Analysis","year":"2009"},{"key":"10.1016\/j.schres.2023.02.011_bb0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0033-3182(95)71666-8","article-title":"Global assessment of functioning: a modified scale","volume":"36","author":"Caldecott-Hazard","year":"1995","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2023.02.011_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/archgenpsychiatry.2007.3","article-title":"Prediction of psychosis in youth at high clinical risk","volume":"65","author":"Cannon","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpsychires.2016.06.021","article-title":"Duration of attenuated positive and negative symptoms in individuals at clinical high risk: associations with risk of conversion to psychosis and functional outcome","volume":"81","author":"Carri\u00f3n","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2023.02.011_bb0055","article-title":"Neurocognitive functioning in individuals at clinical high risk for psychosis: a systematic review and meta-analysis","volume":"16","author":"Catalan","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.schres.2015.01.013","article-title":"Factors contributing to the duration of untreated prodromal positive symptoms in individuals at ultra-high risk for psychosis","volume":"162","author":"Chon","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.02.011_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2017.02.014","article-title":"Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis","volume":"189","author":"Chung","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.02.011_bb0070","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1176\/appi.ajp.2015.13121686","article-title":"Psychosis prevention: a modified clinical high risk perspective from the recognition and prevention (RAP) program","volume":"172","author":"Cornblatt","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1192\/bjp.bp.107.048942","article-title":"Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis","volume":"194","author":"Crumlish","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1192\/bjp.177.6.511","article-title":"Causes and consequences of duration of untreated psychosis in schizophrenia","volume":"177","author":"Drake","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0085","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3389\/fpsyt.2020.00770","article-title":"Mismatch negativity predicts remission and neurocognitive function in individuals at ultra-high risk for psychosis","volume":"11","author":"Fujioka","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1192\/bjp.bp.107.047951","article-title":"Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis","volume":"194","author":"Fusar-Poli","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamapsychiatry.2013.269","article-title":"The psychosis high-risk state: a comprehensive state-of-the-art review","volume":"70","author":"Fusar-Poli","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1192\/bjp.bp.114.157115","article-title":"Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis","volume":"207","author":"Fusar-Poli","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/wps.20446","article-title":"Improving outcomes of first-episode psychosis: an overview","volume":"16","author":"Fusar-Poli","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100578","article-title":"Real-world long-term outcomes in individuals at clinical high risk for psychosis: the case for extending duration of care","volume":"28","author":"Fusar-Poli","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.schres.2023.02.011_bb0120","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1176\/ajp.149.9.1148","article-title":"Revising avis V for DSM-IV: a review of measures of social functioning","volume":"149","author":"Goldman","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4088\/JCP.14074su1c.02","article-title":"Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia","volume":"77","author":"Green","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1034\/j.1600-0447.2000.00008.x","article-title":"Onset and early course as determinants of the further course of schizophrenia","volume":"102","author":"H\u00e4fner","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.02.011_bb0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.schres.2021.02.019","article-title":"The relationship between cognitive deficits and impaired short-term functional outcome in clinical high-risk for psychosis participant: a machine learning and modelling approach","volume":"231","author":"Haining","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.02.011_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/wps.20822","article-title":"The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis","volume":"20","author":"Howes","year":"2021","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0145","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1017\/S0033291708003152","article-title":"Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories","volume":"38","author":"Iyer","year":"2008","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2023.02.011_bb0175","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.schres.2014.04.002","article-title":"Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study","volume":"156","author":"Lee","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.02.011_bb0180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.schres.2014.01.018","article-title":"Neurocognitive function as a possible marker for remission from clinical high risk for psychosis","volume":"153","author":"Lee","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.02.011_bb0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.schres.2009.09.011","article-title":"Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study","volume":"115","author":"Lemos-Gir\u00e1ldez","year":"2009","journal-title":"Schizophrenia Res."},{"key":"10.1016\/j.schres.2023.02.011_bb0190","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/schbul\/sbi031","article-title":"First-episode psychosis: psychopathology, quality of life, and functional outcome","volume":"31","author":"Malla","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.02.011_bb0195","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archpsyc.62.9.975","article-title":"Association between duration of untreated psychosis and outcome in cohorts of first-episode patients","volume":"62","author":"Marshall","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1192\/S0007125000297584","article-title":"Early detection and intervention of schizophrenia: rationale and research","volume":"172","author":"McGlashan","year":"1998","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/oxfordjournals.schbul.a033442","article-title":"The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior","volume":"26","author":"Moller","year":"2000","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.02.011_bb0210","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jamapsychiatry.2013.1270","article-title":"Long-term follow-up of a group at ultra high risk (\u201cprodromal\u201d for psychosis: the PACE 400 study","volume":"70","author":"Nelson","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0215","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1017\/S0033291701003488","article-title":"Duration of untreated psychosis: a critical examination of the concept and its importance","volume":"31","author":"Norman","year":"2001","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2023.02.011_bb0220","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/schbul\/sbz039","article-title":"What causes the onset of psychosis in individuals at clinical high risk? A meta-analysis of risk and protective factors","volume":"46","author":"Oliver","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.02.011_bb0225","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2023.02.011_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(03)12323-9","article-title":"Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison","volume":"25","author":"Pantelis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2023.02.011_bb0235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1192\/bjp.bp.113.127753","article-title":"Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: a systematic review and meta-analysis","volume":"205","author":"Penttil\u00e4","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0240","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/eip.13002","article-title":"Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population","volume":"15","author":"Polari","year":"2021","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0245","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1586\/ern.10.191","article-title":"Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment","volume":"11","author":"Remington","year":"2011","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.schres.2023.02.011_bb0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jad.2016.05.053","article-title":"Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis","volume":"203","author":"Rutigliano","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2023.02.011_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100909","article-title":"Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis","volume":"36","author":"Salazar de Pablo","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.schres.2023.02.011_bb0260","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jamapsychiatry.2021.0830","article-title":"Probability of transition to psychosis in individuals at clinical high risk: an updated meta-analysis","volume":"78","author":"Salazar de Pablo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0265","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796021000639","article-title":"Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis","volume":"31","author":"Salazar de Pablo","year":"2022","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.schres.2023.02.011_bb0270","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/npp.2017.55","article-title":"Relationship between duration of untreated psychosis and intrinsic corticostriatal connectivity in patients with early phase schizophrenia","volume":"42","author":"Sarpal","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2023.02.011_bb0275","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00127-015-1093-3","article-title":"Duration of unspecific prodromal and clinical high risk states, and help-seeking in first-admission psychosis patients","volume":"50","author":"Schultze-Lutter","year":"2015","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.schres.2023.02.011_bb0280","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1176\/appi.ps.201600304","article-title":"Is the clinical high-risk state a valid concept? Retrospective examination in a first-episode psychosis sample","volume":"68","author":"Shah","year":"2017","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2023.02.011_bb0285","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2288-12-57","article-title":"Transformations of summary statistics as input in meta-analysis for linear dose-response models on a logarithmic scale: a methodology developed within EURRECA","volume":"12","author":"Souverein","year":"2012","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.schres.2023.02.011_bb0290","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12888-021-03267-2","article-title":"Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition","volume":"21","author":"Staines","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2023.02.011_bb0295","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1017\/S0033291717002707","article-title":"Duration of untreated prodromal symptoms in a chinese sample at high risk for psychosis: demographic, clinical, and outcome","volume":"48","author":"Zhang","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2023.02.011_bb0300","first-page":"266","article-title":"When to initiate antipsychotic treatment for psychotic symptoms: at the premorbid phase or first episode of psychosis","volume":"156","author":"Zhang","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:54:52Z","timestamp":1778547292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996423000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":54,"alternative-id":["S0920996423000543"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2023.02.011","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and clinical correlates of risk symptoms in individuals at clinical high-risk for psychosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2023.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}